<DOC>
	<DOC>NCT00241319</DOC>
	<brief_summary>The purpose of this study is to establish the efficacy of R89674 0.25% ophthalmic solution compared with placebo in alleviating the signs and symptoms of conjunctival allergen challenge-induced allergic conjunctivitis</brief_summary>
	<brief_title>Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>history of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees within the past 24 months; calculated bestcorrected visual acuity of 0.6 logMar or better in each eye; positive bilateral conjunctival allergy challenge reaction narrow angle glaucoma, clinically significant blepharitis, follicular conjunctivitis, iritis pterygium or diagnosis of dry eye ocular surgical intervention within 3 months history of refractive surgery within 6 months known history of retinal detachment, diabetic retinopathy, or progressive retinal disease presence of active ocular infection positive history of an ocular herpetic infection preauricular lymphadenopath manifest signs or symptoms of clinically active allergic conjunctivitis</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>ocular, allergic conjunctivitis, ophthalmic</keyword>
</DOC>